Chief Psychiatric Officer in Boston, Dr. Brian Boyle, describes how antidepressants vs Spravato works to combat depression.
Spravato, which is covered by major insurances, boosts glutamate, a neurotransmitter in the brain. Spravato works by mostly primarily targeting the NMDA receptors in the brain, which are involved in regulating glutamate levels, a key neurotransmitter responsible for mood regulation.
Schedule a virtual appointment to see if Spravato or Stella's other mental health treatments like transcranial magnetic stimulation (TMS), ketamine infusion therapy, medication management, or the dual sympathetic reset (an advanced stellate ganglion block) can help you: https://form.jotform.com/233115517341245?utm_source=youtube&utm_medium=organic
#stellamentalhealth #depression #depressiontreatment #mdd #trd #boston #brookline #stellacenter